[Image courtesy Atlantic Therapeutics]
1. Atlantic Therapeutics: Stress urinary incontinence treatment device
Atlantic Therapeutics is showcasing its Innovo stress urinary incontinence device at CES 2021.
The direct-to-consumer and FDA-approved device works by delivering non-invasive pelvic floor stimulation through wearable technology. The neuromuscular electrical stimulation technology is embedded in a pair of shorts to strengthen and re-educate pelvic floor muscles, according to the company.
Innovo said results from a clinical study demonstrated that 80% of Innovo users experienced significant improvements after four weeks and 87% were considered “dry” or “near dry” after three months. Four-fifths of users also found Innovo significantly improved their quality of life.
